← All companies
Summit Therapeutics Inc.
SMMT - CIK 0001599298
Market cap$10.13 B
Rank#935
SEC filings532
The table below shows Summit Therapeutics Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $225.27M | $104.86M | $71.42M | $348.61M | - | $66.42M |
| Short-term investments | $488.18M | $307.49M | $114.82M | - | - | - |
| Receivables | - | - | $0.00 | $349.00K | $1.46M | $331.00K |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.